Painful and painless channelopathies

The Lancet Neurology

Volumn 13, Issue 6, 2014, Pages 587-599

  Bennett, David L H ^a   Woods, C Geoffrey ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; ANALGESIC AGENT; SODIUM CHANNEL NAV1.7; SODIUM CHANNEL NAV1.8; SODIUM CHANNEL NAV1.9; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

CHANNELOPATHY; CONGENITAL ANALGESIA; ERYTHROMELALGIA; FAMILIAL EPISODIC PAIN SYNDROME; GAIN OF FUNCTION MUTATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; NEUROPATHY; NOCICEPTION; NONHUMAN; PAIN; PAIN RECEPTOR; PAROXYSMAL EXTREME PAIN DISORDER; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PSYCHOGENIC PAIN; REVIEW; SENSORY DYSFUNCTION; SENSORY NERVE CELL; SMALL FIBRE NEUROPATHY; CHRONIC PAIN; DISEASE ASSOCIATION; GENE FUNCTION; PAINFUL CHANNELOPATHY; PAINLESS CHANNELOPATHY; PHENOTYPE;

CALCIUM CHANNELS; CHANNELOPATHIES; HUMANS; MUTATION; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; NAV1.8 VOLTAGE-GATED SODIUM CHANNEL; NAV1.9 VOLTAGE-GATED SODIUM CHANNEL; NERVE TISSUE PROTEINS; PAIN; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84901234337     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70024-9     Document Type: Review

References (110)

1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006, 10:287-333.
2. Sherrington CS Qualitative difference of spinal reflex corresponding with qualitative difference of cutaneous stimulus. J Physiol 1903, 30:39-46.
3. Reichling DB, Green PG, Levine JD The fundamental unit of pain is the cell. Pain 2013, 154(suppl 1):S2-S9.
4. Dubin AE, Patapoutian A Nociceptors: the sensors of the pain pathway. J Clin Invest 2010, 120:3760-3772.
5. Snider WD, McMahon SB Tackling pain at the source: new ideas about nociceptors. Neuron 1998, 20:629-632.
6. Hao J, Padilla F, Dandonneau M, et al. Kv1.1 channels act as mechanical brake in the senses of touch and pain. Neuron 2013, 77:899-914.
7. Kim YS, Chu Y, Han L, et al. Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain. Neuron 2014, 81:873-887.
8. Dolphin AC Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond. Nat Rev Neurosci 2012, 13:542-555.
9. Tracey I, Mantyh PW The cerebral signature for pain perception and its modulation. Neuron 2007, 55:377-391.
10. Patapoutian A, Tate S, Woolf CJ Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 2009, 8:55-68.
11. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
12. Tominaga M, Caterina MJ, Malmberg AB, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21:531-543.
13. Bandell M, Story GM, Hwang SW, et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004, 41:849-857.
14. Jordt SE, Bautista DM, Chuang HH, et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 2004, 427:260-265.
15. Peier AM, Moqrich A, Hergarden AC, et al. A TRP channel that senses cold stimuli and menthol. Cell 2002, 108:705-715.
16. Macpherson LJ, Xiao B, Kwan KY, et al. An ion channel essential for sensing chemical damage. J Neurosci 2007, 27:11412-11415.
17. Kwan KY, Glazer JM, Corey DP, Rice FL, Stucky CL TRPA1 modulates mechanotransduction in cutaneous sensory neurons. J Neurosci 2009, 29:4808-4819.
18. McMahon S, Koltzenburg M The changing role of primary afferent neurones in pain. Pain 1990, 43:269-272.
19. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002, 36:57-68.
20. Schmidt M, Dubin AE, Petrus MJ, Earley TJ, Patapoutian A Nociceptive signals induce trafficking of TRPA1 to the plasma membrane. Neuron 2009, 64:498-509.
21. Yao X, Kwan HY, Huang Y Regulation of TRP channels by phosphorylation. Neurosignals 2005, 14:273-280.
22. Toledo-Aral JJ, Moss BL, He ZJ, et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci USA 1997, 94:1527-1532.
23. Akopian AN, Sivilotti L, Wood JN A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 1996, 379:257-262.
24. Dib-Hajj SD, Tyrrell L, Black JA, Waxman SG NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc Natl Acad Sci USA 1998, 95:8963-8968.
25. Djouhri L, Newton R, Levinson SR, Berry CM, Carruthers B, Lawson SN Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel alpha subunit protein. J Physiol 2003, 546:565-576.
26. Black JA, Frézel N, Dib-Hajj SD, Waxman SG Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn. Mol Pain 2012, 8:82.
27. Cummins TR, Howe JR, Waxman SG Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 1998, 18:9607-9619.
28. Weiss J, Pyrski M, Jacobi E, et al. Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature 2011, 472:186-190.
29. Minett MS, Nassar MA, Clark AK, et al. Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat Commun 2012, 3:791.
30. Blair NT, Bean BP Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J Neurosci 2002, 22:10277-10290.
31. Renganathan M, Cummins TR, Waxman SG Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J Neurophysiol 2001, 86:629-640.
32. Dib-Hajj S, Black JA, Cummins TR, Waxman SG NaN/Nav1.9: a sodium channel with unique properties. Trends Neurosci 2002, 25:253-259.
33. Herzog RI, Cummins TR, Waxman SG Persistent TTX-resistant Na+ current affects resting potential and response to depolarization in simulated spinal sensory neurons. J Neurophysiol 2001, 86:1351-1364.
34. Priest BT, Murphy BA, Lindia JA, et al. Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci USA 2005, 102:9382-9387.
35. Ostman JA, Nassar MA, Wood JN, Baker MD GTP up-regulated persistent Na+ current and enhanced nociceptor excitability require NaV1.9. J Physiol 2008, 586:1077-1087.
36. Rotthier A, Baets J, Timmerman V, Janssens K Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat Rev Neurol 2012, 8:73-85.
37. Crowley C, Spencer SD, Nishimura MC, et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994, 76:1001-1011.
38. Einarsdottir E, Carlsson A, Minde J, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet 2004, 13:799-805.
39. Indo Y, Tsuruta M, Hayashida Y, et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 1996, 13:485-488.
40. Baxter DW, Olszewski J Congenital universal insensitivity to pain. Brain 1960, 83:381-393.
41. Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006, 444:894-898.
42. Goldberg YP, MacFarlane J, MacDonald ML, et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 2007, 71:311-319.
43. Ahmad S, Dahllund L, Eriksson AB, et al. A stop codon mutation in SCN9A causes lack of pain sensation. Hum Mol Genet 2007, 16:2114-2121.
44. Cox JJ, Sheynin J, Shorer Z, et al. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Hum Mutat 2010, 31:E1670-E1686.
45. Staud R, Price DD, Janicke D, et al. Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain. Eur J Pain 2011, 15:223-230.
46. Klein CJ, Wu Y, Kilfoyle DH, et al. Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia. J Neurol Neurosurg Psychiatry 2013, 84:386-391.
47. Nilsen KB, Nicholas AK, Woods CG, Mellgren SI, Nebuchennykh M, Aasly J Two novel SCN9A mutations causing insensitivity to pain. Pain 2009, 143:155-158.
48. Yuan J, Matsuura E, Higuchi Y, et al. Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation. Neurology 2013, 80:1641-1649.
49. Leipold E, Liebmann L, Korenke GC, et al. A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet 2013, 45:1399-1404.
50. Mitchell SW On a rare vaso-motor neurosis of the extremities, and on the maladies with which it may be confounded. Am J Med Sci 1878, 151:17-36.
51. Drenth JP, Waxman SG Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest 2007, 117:3603-3609.
52. Segerdahl AR, Xie J, Paterson K, Ramirez JD, Tracey I, Bennett DL Imaging the neural correlates of neuropathic pain and pleasurable relief associated with inherited erythromelalgia in a single subject with quantitative arterial spin labelling. Pain 2012, 153:1122-1127.
53. Cregg R, Laguda B, Werdehausen R, et al. Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia. Neuromolecular Med 2013, 15:265-278.
54. Yang Y, Wang Y, Li S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 2004, 41:171-174.
55. Fischer TZ, Waxman SG Familial pain syndromes from mutations of the NaV1.7 sodium channel. Ann NY Acad Sci 2010, 1184:196-207.
56. Yarov-Yarovoy V, Baker D, Catterall WA Voltage sensor conformations in the open and closed states in ROSETTA structural models of K(+) channels. Proc Natl Acad Sci USA 2006, 103:7292-7297.
57. Dib-Hajj SD, Rush AM, Cummins TR, et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 2005, 128:1847-1854.
58. Orstavik K, Weidner C, Schmidt R, et al. Pathological C-fibres in patients with a chronic painful condition. Brain 2003, 126:567-578.
59. Han C, Dib-Hajj SD, Lin Z, et al. Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation. Brain 2009, 132:1711-1722.
60. Han C, Lampert A, Rush AM, et al. Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav1.7. Mol Pain 2007, 3:3.
61. Han C, Rush AM, Dib-Hajj SD, et al. Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol 2006, 59:553-558.
62. Choi JS, Zhang L, Dib-Hajj SD, et al. Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off. Exp Neurol 2009, 216:383-389.
63. Yang Y, Dib-Hajj SD, Zhang J, et al. Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Na(V)1.7 mutant channel. Nat Commun 2012, 3:1186.
64. Goldberg YP, Price N, Namdari R, et al. Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker. Pain 2012, 153:80-85.
65. Hayden R, Grossman M Rectal, ocular, and submaxillary pain; a familial autonomic disorder related to proctalgia fugaz: report of a family. AMA J Dis Child 1959, 97:479-482.
66. Fertleman CR, Ferrie CD, Aicardi J, et al. Paroxysmal extreme pain disorder (previously familial rectal pain syndrome). Neurology 2007, 69:586-595.
67. Choi JS, Boralevi F, Brissaud O, et al. Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons. Nat Rev Neurol 2011, 7:51-55.
68. Dib-Hajj SD, Estacion M, Jarecki BW, et al. Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable. Mol Pain 2008, 4:37.
69. Fertleman CR, Baker MD, Parker KA, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006, 52:767-774.
70. Jarecki BW, Piekarz AD, Jackson JO, Cummins TR Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents. J Clin Invest 2010, 120:369-378.
71. Estacion M, Dib-Hajj SD, Benke PJ, et al. NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci 2008, 28:11079-11088.
72. Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG Small-fibre neuropathies: advances in diagnosis, pathophysiology and management. Nat Rev Neurol 2012, 8:369-379.
73. Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008, 131:1912-1925.
74. Faber CG, Hoeijmakers JG, Ahn HS, et al. Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012, 71:26-39.
75. Estacion M, Han C, Choi JS, et al. Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7. Mol Pain 2011, 7:92.
76. Han C, Hoeijmakers JG, Ahn HS, et al. Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability. Neurology 2012, 78:1635-1643.
77. Persson AK, Liu S, Faber CG, Merkies IS, Black JA, Waxman SG Neuropathy-associated Nav1.7 variant I228M impairs integrity of dorsal root ganglion neuron axons. Ann Neurol 2013, 73:140-145.
78. Faber CG, Lauria G, Merkies IS, et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci USA 2012, 109:19444-19449.
79. Kremeyer B, Lopera F, Cox JJ, et al. A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron 2010, 66:671-680.
80. Zhang XY, Wen J, Yang W, et al. Gain-of-function mutations in SCN11A cause familial episodic pain. Am J Hum Genet 2013, 93:957-966.
81. Estacion M, Harty TP, Choi JS, Tyrrell L, Dib-Hajj SD, Waxman SG A sodium channel gene SCN9A polymorphism that increases nociceptor excitability. Ann Neurol 2009, 66:862-866.
82. Reimann F, Cox JJ, Belfer I, et al. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci USA 2010, 107:5148-5153.
83. Valdes AM, Arden NK, Vaughn FL, et al. Role of the Nav1.7 R1150W amino acid change in susceptibility to symptomatic knee osteoarthritis and multiple regional pain. Arthritis Care Res (Hoboken) 2011, 63:440-444.
84. Holliday KL, Thomson W, Neogi T, et al. The non-synonymous SNP, R1150W, in SCN9A is not associated with chronic widespread pain susceptibility. Mol Pain 2012, 8:72.
85. Greenbaum L, Tegeder I, Barhum Y, Melamed E, Roditi Y, Djaldetti R Contribution of genetic variants to pain susceptibility in Parkinson disease. Eur J Pain 2012, 16:1243-1250.
86. Duan G, Xiang G, Zhang X, Yuan R, Zhan H, Qi D A single-nucleotide polymorphism in SCN9A may decrease postoperative pain sensitivity in the general population. Anesthesiology 2013, 118:436-442.
87. Neely GG, Hess A, Costigan M, et al. A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell 2010, 143:628-638.
88. Costigan M, Belfer I, Griffin RS, et al. Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain 2010, 133:2519-2527.
89. Hendry L, Lombard Z, Wadley A, Kamerman P KCNS1, but not GCH1, is associated with pain intensity in a black southern African population with HIV-associated sensory neuropathy: a genetic association study. J Acquir Immune Defic Syndr 2013, 63:27-30.
90. Nissenbaum J, Devor M, Seltzer Z, et al. Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. Genome Res 2010, 20:1180-1190.
91. Sorge RE, Trang T, Dorfman R, et al. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med 2012, 18:595-599.
92. von Hehn CA, Baron R, Woolf CJ Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012, 73:638-652.
93. Norbury TA, MacGregor AJ, Urwin J, Spector TD, McMahon SB Heritability of responses to painful stimuli in women: a classical twin study. Brain 2007, 130:3041-3049.
94. Binder A, May D, Baron R, et al. Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients. PLoS One 2011, 6:e17387.
95. Tsantoulas C, Zhu L, Shaifta Y, et al. Sensory neuron downregulation of the Kv9.1 potassium channel subunit mediates neuropathic pain following nerve injury. J Neurosci 2012, 32:17502-17513.
96. Volonté C, Apolloni S, Skaper SD, Burnstock G P2X7 receptors: channels, pores and more. CNS Neurol Disord Drug Targets 2012, 11:705-721.
97. Goldstein DB Common genetic variation and human traits. N Engl J Med 2009, 360:1696-1698.
98. Moore A, Derry S, Eccleston C, Kalso E Expect analgesic failure; pursue analgesic success. BMJ 2013, 346:f2690.
99. Copel C, Clerc N, Osorio N, Delmas P, Mazet B The Nav1.9 channel regulates colonic motility in mice. Front Neurosci 2013, 7:58.
100. Scanio MJ, Shi L, Drizin I, et al. Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain. Bioorg Med Chem 2010, 18:7816-7825.
101. Bezzina CR, Barc J, Mizusawa Y, et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet 2013, 45:1044-1049.
102. Emery EC, Young GT, Berrocoso EM, Chen L, McNaughton PA HCN2 ion channels play a central role in inflammatory and neuropathic pain. Science 2011, 333:1462-1466.
103. Ludwig A, Budde T, Stieber J, et al. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J 2003, 22:216-224.
104. Borer JS, Fox K, Jaillon P, Lerebours G Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003, 107:817-823. the Ivabradine Investigators Group.
105. Binshtok AM, Bean BP, Woolf CJ Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature 2007, 449:607-610.
106. Foo JN, Liu JJ, Tan EK Whole-genome and whole-exome sequencing in neurological diseases. Nat Rev Neurol 2012, 8:508-517.
107. Mogil JS Pain genetics: past, present and future. Trends Genet 2012, 28:258-266.
108. Lacroix-Fralish ML, Ledoux JB, Mogil JS The Pain Genes Database: an interactive web browser of pain-related transgenic knockout studies. Pain 2007, 131:3.e1-3.e4.
109. Perkins JR, Lees J, Antunes-Martins A, et al. PainNetworks: a web-based resource for the visualisation of pain-related genes in the context of their network associations. Pain 2013, 154:e1-12.
110. Chambers SM, Qi Y, Mica Y, et al. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol 2012, 30:715-720.